Key Takeaways
- E-2 CRO, testing lab, and life science service company owners qualify for Bankable funding based on contracted revenue
- Lab equipment, facility expansion, and scientific staff hiring are all eligible uses
- Israeli, Indian, South Korean, and Japanese E-2 investors establish US biotech service operations
- GLP-compliant lab equipment and FDA-regulated testing services are well-understood by Bankable
- Funding from $300K to $5M with 48-hour preliminary decisions for established labs
The biotech and life science services sector has seen significant E-2 investment from scientific entrepreneurs in Israel, South Korea, India, and Japan who establish US-based contract research organizations (CROs), analytical testing laboratories, clinical supply companies, and regulatory consulting firms. These businesses serve the pharmaceutical and biotech industry with services ranging from drug testing and stability studies to GMP manufacturing support and regulatory submission preparation. The service contracts with pharma and biotech clients are among the most creditworthy in any industry — these are companies with deep pockets and contractual payment obligations.
Life science service revenue is documented through signed master service agreements, project work orders, and invoiced services that Bankable can evaluate with the same precision that the FDA expects from your quality management systems. Whether you operate an analytical chemistry lab, a microbiology testing service, or a bioanalytical CRO, your client contracts tell a clear revenue story.
Biotech Lab Capital Uses
- Analytical instruments: HPLC, mass spectrometers, PCR systems, microscopes, and specialty analytical equipment
- Facility expansion: Clean rooms, BSL-2 containment, and specialized lab buildouts
- Scientific staff: Hiring PhD-level scientists, laboratory technicians, and QA/regulatory staff
- Accreditation: ISO 17025, CAP, CLIA, or GLP compliance program costs
- Validation studies: Method development and validation required for client contract execution
Equipment Financing
Fund analytical instruments and lab equipment with asset-backed terms.
Learn More →Working Capital
Fund the gap between contract award and first client payment for large research projects.
Learn More →Medical Devices Funding
Capital for E-2 investors in medical device manufacturing and testing.
Learn More →Frequently Asked Questions
Yes. E-2 CRO and laboratory service owners with documented pharma and biotech client revenue qualify for Bankable funding. No green card required.
Analytical testing labs, CROs, bioanalytical labs, stability storage facilities, regulatory consulting firms, and clinical supply companies qualify.
We accept master service agreements, project work orders, invoice aging reports, and bank statements showing pharma client payment deposits.
Yes. HPLC, mass spectrometers, and other analytical instruments qualify for equipment-backed financing.
Most Bankable biotech lab clients have $600K+ in annual service revenue from pharma or biotech clients.
Yes. Scientific staff expansion is a common capital use for growing CROs and testing labs.
Yes. Our underwriters are familiar with regulated laboratory environments and can evaluate documentation accordingly.
Yes. ISO 17025, CAP, and CLIA accreditation program costs are eligible working capital uses.